Results 241 to 250 of about 4,748,303 (367)

Optimized Protocol for DNA Extraction in Three <i>Theobroma</i> Species. [PDF]

open access: yesBio Protoc
Riascos-España AF   +4 more
europepmc   +1 more source

Detection of Bacteria in Environmental Samples by Direct PCR Without DNA Extraction [PDF]

open access: gold, 2001
K.A. Fode-Vaughan   +3 more
openalex   +1 more source

Interplay of integrins and selectins in metastasis

open access: yesMolecular Oncology, EarlyView.
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva   +2 more
wiley   +1 more source

Non-destructive seed genotyping via microneedle-based DNA extraction. [PDF]

open access: yesPlant Biotechnol J
Li M   +13 more
europepmc   +1 more source

Rapid DNA Extraction from a Bloom-forming Cyanobacterium.

open access: bronze, 1999
Ryuji Kondo   +4 more
openalex   +2 more sources

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

DNA extraction protocols for animal fecal material on blood spot cards. [PDF]

open access: yesPLoS One
Llarena AK   +8 more
europepmc   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy